Cell Biology News and Research

RSS

UTSW study provides a potential avenue for the development of new antivirals against influenza

A collaborative study from UT Southwestern scientists has identified a new function for a protein called TAO2 that appears to be key to inhibiting replication of the influenza virus, which sickens millions of individuals worldwide each year and kills hundreds of thousands.

20 Jun 2022

Two broadly neutralizing antibodies show promise to provide long-acting immunity against SARS-CoV-2

Two broadly neutralizing antibodies show great promise to provide long-acting immunity against COVID-19 in immunocompromised populations according to a paper published June 15 in the Journal of Experimental Medicine (JEM).

15 Jun 2022

SARS-CoV-2 damages cilia

Researchers determine whether the interaction between ORF10 and ZYG11B promotes the dissemination of SARS-CoV-2.

15 Jun 2022

Research reveals a potential Achilles heel in the protective layers surrounding Gram-negative bacteria

A new study published in Nature today has identified a potential Achilles heel in the protective layers surrounding Gram-negative bacteria that could aid in the development of next-generation antibiotics.

15 Jun 2022

seqWell appoints Dr Amy Liao to Board of Directors

seqWell, a global provider of genomic library workflow solutions including the plexWell™ next-generation sequencing (NGS) multiplexing technology, today announced the appointment of Dr Amy Liao to its Board.

From seqWell 14 Jun 2022

Stress protein in fibroblasts appears to be an attractive cancer drug target

A stress protein that is overactive in many types of tumor cells also has a key role in tumor-supporting cells called fibroblasts, and may be a good target for future cancer treatments, suggests a study from researchers at the Perelman School of Medicine at the University of Pennsylvania.

10 Jun 2022

First-in-class, anti-cancer mitochondrial drug found to be effective against most carcinoma cell lines

A study of the lead agent (CPI-613) in a class of anticancer drugs undergoing Food and Drug Administration (FDA) approved clinical trials reveals that CPI-613 is effective against most carcinoma cell lines, and, used in combination, could have efficacy against reducing some tumors.

9 Jun 2022

Advanced microscopy techniques offer detailed insight into inner workings of cells' powerhouses

Using advanced microscopy techniques, researchers at Karolinska Institutet and Stockholm University in Sweden have visualized in unprecedented detail the machinery that the cells' powerhouses, the mitochondria, use to form their proteins.

8 Jun 2022

Open multiplexing with Cell DIVE offers cancer researchers more choices

Leica has introduced a new generation of its multiplexed imaging solution, Cell DIVE, including software and hardware improvements. The more scalable and efficient multiplexing platform addresses spatial cell biology and function within the tissue microenvironment

From Leica Microsystems GmbH 8 Jun 2022

Irregularities in production of brain cells may lead to autism spectrum disorder, finds study

Analyzing brain stem cells of patients with autism spectrum disorder (ASD), Rutgers scientists have found evidence of irregularities in very early brain development that may contribute to the neuropsychiatric disorder.

8 Jun 2022

Scientists provide crucial insights into the roles of inflammation and oxidative stress in certain cancers

Rampant inflammation has long been linked to cancer but exactly how it pushes healthy cells to transform into malignant ones has remained a mystery.

7 Jun 2022

MIT researchers identify components of mucus that can inhibit fungal infections

Candida albicans is a yeast that often lives in the human digestive tract and mouth, as well as urinary and reproductive organs.

6 Jun 2022

Curia Adopts the Berkeley Lights Platform to Expand its Antibody Discovery Capabilities

Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, and Curia, formerly AMRI, a leading contract research, development and manufacturing organization (CDMO), today announced Curia’s adoption of The Beacon® Optofluidic system and workflows from Berkeley Lights to accelerate and expand its antibody-based drug discovery capabilities.

From Bruker Cellular Analysis 6 Jun 2022

Cell Biology News and Research

UTSW study provides a potential avenue for the development of new antivirals against influenza

Two broadly neutralizing antibodies show promise to provide long-acting immunity against SARS-CoV-2

SARS-CoV-2 damages cilia

Research reveals a potential Achilles heel in the protective layers surrounding Gram-negative bacteria

seqWell appoints Dr Amy Liao to Board of Directors

Stress protein in fibroblasts appears to be an attractive cancer drug target

First-in-class, anti-cancer mitochondrial drug found to be effective against most carcinoma cell lines

Advanced microscopy techniques offer detailed insight into inner workings of cells' powerhouses

Open multiplexing with Cell DIVE offers cancer researchers more choices

Irregularities in production of brain cells may lead to autism spectrum disorder, finds study

Scientists provide crucial insights into the roles of inflammation and oxidative stress in certain cancers

MIT researchers identify components of mucus that can inhibit fungal infections

Curia Adopts the Berkeley Lights Platform to Expand its Antibody Discovery Capabilities

Easily Acquire Expert-Quality Images with the APEXVIEW™ APX100 All-in-One Microscope

New study in mice shows alternate origins of plaques in Alzheimer’s disease

Scientists identify a new pneumococcal vaccine candidate

Aerobic exercise amplifies the effects of immunotherapy to reduce pancreatic tumor growth

New study uncovers the impact of genetic mutations on lifelong blood cell production

Study identifies how ketamine works as a rapid antidepressant

Scientists unlock the cellular secrets of aging process

Driving innovation in drug discovery with in vitro biology solutions eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News